• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于镧系元素的纳米颗粒与孟加拉玫瑰红共轭用于荧光共振能量转移介导的X射线诱导光动力疗法。

Lanthanides-Based Nanoparticles Conjugated with Rose Bengal for FRET-Mediated X-Ray-Induced PDT.

作者信息

Dhaini Batoul, Daouk Joël, Schohn Hervé, Arnoux Philippe, Jouan-Hureaux Valérie, Moussaron Albert, Hagege Agnès, Achard Mathilde, Acherar Samir, Hamieh Tayssir, Frochot Céline

机构信息

Université de Lorraine, CNRS, LRGP, F-54000 Nancy, France.

Laboratory of Materials, Catalysis, Environment and Analytical Methods (MCEMA), Faculty of Sciences I, Lebanese University, Beirut P.O. Box 6573/1, Lebanon.

出版信息

Pharmaceuticals (Basel). 2025 May 1;18(5):672. doi: 10.3390/ph18050672.

DOI:10.3390/ph18050672
PMID:40430491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12114895/
Abstract

In order to find a good candidate for Förster Resonance Energy Transfer (FRET)-mediated X-ray-induced photodynamic therapy (X-PDT) for the treatment of cancer, lanthanide (Ln)-based AGuIX nanoparticles (NPs) conjugated with Rose Bengal (RB) as a photosensitizer (PS) were synthesized. X-PDT overcomes the problem of the poor penetration of visible light into tissues, which limits the efficacy of PDT in the treatment of deep-seated tumors. It is essential to optimize FRET efficiency by maximizing the overlap integral between donor emission and acceptor absorption and lengthening the duration of the donor emission. In this study, we optimized energy transfer between a scintillator (Sc) as a donor and a PS as an acceptor. Terbium (Tb) and Gadolinium (Gd) as Scs and Rose RB as a PS were chosen. The study of energy transfer between Tb, Gd and RB in solution and chelated on AGuIX NPs proved to be FRET-like. RB was conjugated directly onto AGuIX NPs (i.e., AGuIX Ln@RB), and the use of a spacer arm (i.e., AGuIX Ln@spacer arm-RB) increased FRET efficiency. Singlet oxygen production by these NPs was observed under UV-visible illumination and X-ray irradiation. The in vitro bioassay demonstrated 52% cell death of U-251MG derived from human malignant glioblastoma multiforme at a concentration of 1 μM RB after illumination and irradiation (2 Gy, 320 kV, 10 mA, 3 Gy/min at 47 cm). In addition, the RB-coupled NRP-1-targeting peptide (i.e., K(RB)DKPPR) was conjugated onto AGuIX NPs by a thiol-maleimide click chemistry reaction, and an affinity in the nM range was observed.

摘要

为了找到一种用于癌症治疗的基于荧光共振能量转移(FRET)介导的X射线诱导光动力疗法(X-PDT)的优良候选物,合成了与作为光敏剂(PS)的孟加拉玫瑰红(RB)共轭的镧系(Ln)基AGuIX纳米颗粒(NPs)。X-PDT克服了可见光对组织穿透性差的问题,而这一问题限制了PDT在深部肿瘤治疗中的疗效。通过最大化供体发射与受体吸收之间的重叠积分并延长供体发射持续时间来优化FRET效率至关重要。在本研究中,我们优化了作为供体的闪烁体(Sc)与作为受体的PS之间的能量转移。选择了铽(Tb)和钆(Gd)作为Sc,玫瑰红RB作为PS。对溶液中以及螯合在AGuIX NPs上的Tb、Gd和RB之间的能量转移研究证明具有类FRET性质。RB直接共轭到AGuIX NPs上(即AGuIX Ln@RB),使用间隔臂(即AGuIX Ln@间隔臂-RB)提高了FRET效率。在紫外-可见光照射和X射线照射下观察到这些NPs产生单线态氧。体外生物测定表明,在光照和照射(2 Gy,320 kV,10 mA,47 cm处3 Gy/min)后,浓度为1 μM RB时,源自人多形性恶性胶质母细胞瘤的U-251MG细胞有52%死亡。此外,通过硫醇-马来酰亚胺点击化学反应将RB偶联的NRP-1靶向肽(即K(RB)DKPPR)共轭到AGuIX NPs上,并观察到其在纳摩尔范围内的亲和力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/e116654c7dae/pharmaceuticals-18-00672-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/372c36249576/pharmaceuticals-18-00672-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/57682f4b9efc/pharmaceuticals-18-00672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/f717345e6cf1/pharmaceuticals-18-00672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/51463dc75ab1/pharmaceuticals-18-00672-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/6b373d67429f/pharmaceuticals-18-00672-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/5304dadf68e7/pharmaceuticals-18-00672-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/5e3c5e834823/pharmaceuticals-18-00672-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/021c2cec774c/pharmaceuticals-18-00672-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/29daaadd30ed/pharmaceuticals-18-00672-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/ffb9fc7f97b1/pharmaceuticals-18-00672-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/2abd6cdd223b/pharmaceuticals-18-00672-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/dacb119e2589/pharmaceuticals-18-00672-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/d0011953beb5/pharmaceuticals-18-00672-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/e116654c7dae/pharmaceuticals-18-00672-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/372c36249576/pharmaceuticals-18-00672-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/57682f4b9efc/pharmaceuticals-18-00672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/f717345e6cf1/pharmaceuticals-18-00672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/51463dc75ab1/pharmaceuticals-18-00672-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/6b373d67429f/pharmaceuticals-18-00672-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/5304dadf68e7/pharmaceuticals-18-00672-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/5e3c5e834823/pharmaceuticals-18-00672-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/021c2cec774c/pharmaceuticals-18-00672-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/29daaadd30ed/pharmaceuticals-18-00672-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/ffb9fc7f97b1/pharmaceuticals-18-00672-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/2abd6cdd223b/pharmaceuticals-18-00672-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/dacb119e2589/pharmaceuticals-18-00672-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/d0011953beb5/pharmaceuticals-18-00672-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f96/12114895/e116654c7dae/pharmaceuticals-18-00672-g013.jpg

相似文献

1
Lanthanides-Based Nanoparticles Conjugated with Rose Bengal for FRET-Mediated X-Ray-Induced PDT.基于镧系元素的纳米颗粒与孟加拉玫瑰红共轭用于荧光共振能量转移介导的X射线诱导光动力疗法。
Pharmaceuticals (Basel). 2025 May 1;18(5):672. doi: 10.3390/ph18050672.
2
Ultra-high FRET efficiency NaGdF: Tb-Rose Bengal biocompatible nanocomposite for X-ray excited photodynamic therapy application.用于 X 射线激发光动力治疗应用的超高 FRET 效率 NaGdF4: Tb-玫瑰红生物相容性纳米复合材料。
Biomaterials. 2018 Nov;184:31-40. doi: 10.1016/j.biomaterials.2018.09.001. Epub 2018 Sep 5.
3
Energy Transfer between AGuIX Nanoparticles and Photofrin under Light or X-ray Excitation for PDT Applications.用于光动力疗法的 AGuIX 纳米颗粒与光敏剂在光或 X 射线激发下的能量转移
Pharmaceuticals (Basel). 2024 Aug 5;17(8):1033. doi: 10.3390/ph17081033.
4
Low-Dose X-ray Excited Photodynamic Therapy Based on NaLuF:Tb-Rose Bengal Nanocomposite.基于 NaLuF:Tb-玫瑰红纳米复合物的低剂量 X 射线激发光动力疗法。
Bioconjug Chem. 2019 Aug 21;30(8):2191-2200. doi: 10.1021/acs.bioconjchem.9b00429. Epub 2019 Aug 6.
5
Terbium-Based AGuIX-Design Nanoparticle to Mediate X-ray-Induced Photodynamic Therapy.基于铽的AGuIX设计纳米颗粒介导X射线诱导的光动力疗法。
Pharmaceuticals (Basel). 2021 Apr 22;14(5):396. doi: 10.3390/ph14050396.
6
Added Value of Scintillating Element in Cerenkov-Induced Photodynamic Therapy.切伦科夫诱导光动力疗法中闪烁元件的附加值
Pharmaceuticals (Basel). 2023 Jan 18;16(2):143. doi: 10.3390/ph16020143.
7
Highly Efficient FRET System Capable of Deep Photodynamic Therapy Established on X-ray Excited Mesoporous LaF3:Tb Scintillating Nanoparticles.基于X射线激发的介孔LaF3:Tb闪烁纳米粒子建立的高效FRET系统,可用于深度光动力治疗。
ACS Appl Mater Interfaces. 2015 Jun 10;7(22):12261-9. doi: 10.1021/acsami.5b03067. Epub 2015 May 26.
8
Photosensitiser functionalised luminescent upconverting nanoparticles for efficient photodynamic therapy of breast cancer cells.光敏剂功能化上转换发光纳米粒子用于乳腺癌细胞的高效光动力治疗。
Photochem Photobiol Sci. 2019 Jan 1;18(1):98-109. doi: 10.1039/c8pp00354h. Epub 2018 Oct 17.
9
Terbium-Rose Bengal Coordination Nanocrystals-Induced ROS Production under Low-Dose X-rays in Cultured Cancer Cells for Photodynamic Therapy.低剂量 X 射线激发碲化铕-玫瑰红配合物纳米晶产生活性氧用于光动力治疗。
ACS Appl Bio Mater. 2023 Jun 19;6(6):2505-2513. doi: 10.1021/acsabm.3c00304. Epub 2023 Jun 8.
10
Rose Bengal Decorated NaYF:Tb Nanoparticles for Low Dose X-ray-Induced Photodynamic Therapy in Cancer Cells.用于癌细胞低剂量X射线诱导光动力疗法的玫瑰红修饰的NaYF:Tb纳米颗粒
ACS Appl Bio Mater. 2022 Nov 21;5(11):5477-5486. doi: 10.1021/acsabm.2c00801. Epub 2022 Nov 1.

本文引用的文献

1
Transformative clinical trials in gynaecologic radiation oncology in 2023-2024: Shaping modern treatment practices.2023 - 2024年妇科放射肿瘤学的变革性临床试验:塑造现代治疗实践
Cancer Radiother. 2024 Dec;28(8):719-726. doi: 10.1016/j.canrad.2024.10.002. Epub 2024 Nov 22.
2
Energy Transfer between AGuIX Nanoparticles and Photofrin under Light or X-ray Excitation for PDT Applications.用于光动力疗法的 AGuIX 纳米颗粒与光敏剂在光或 X 射线激发下的能量转移
Pharmaceuticals (Basel). 2024 Aug 5;17(8):1033. doi: 10.3390/ph17081033.
3
The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy.
纳米材料在推进深部肿瘤光动力疗法(PDT)及与放射疗法协同作用中的应用。
Front Bioeng Biotechnol. 2023 Oct 2;11:1250804. doi: 10.3389/fbioe.2023.1250804. eCollection 2023.
4
X-ray excited luminescent nanoparticles for deep photodynamic therapy.用于深部光动力治疗的X射线激发发光纳米颗粒
RSC Adv. 2023 Oct 16;13(43):30133-30150. doi: 10.1039/d3ra04984a. eCollection 2023 Oct 11.
5
New Crystal Form of Human Neuropilin-1 b1 Fragment with Six Electrostatic Mutations Complexed with KDKPPR Peptide Ligand.新型人神经纤毛蛋白-1 b1 片段六静电突变体与 KDKPPR 肽配体复合物的晶体结构。
Molecules. 2023 Jul 24;28(14):5603. doi: 10.3390/molecules28145603.
6
X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy.用于深部组织光动力疗法的X射线激活纳米平台
Nanomaterials (Basel). 2023 Feb 9;13(4):673. doi: 10.3390/nano13040673.
7
Importance of Rose Bengal Loaded with Nanoparticles for Anti-Cancer Photodynamic Therapy.负载纳米颗粒的孟加拉玫瑰红在抗癌光动力疗法中的重要性。
Pharmaceuticals (Basel). 2022 Aug 31;15(9):1093. doi: 10.3390/ph15091093.
8
Design of a Targeting and Oxygen-Independent Platform to Improve Photodynamic Therapy: A Proof of Concept.靶向和乏氧依赖性平台设计以改善光动力疗法:概念验证。
ACS Appl Bio Mater. 2021 Feb 15;4(2):1330-1339. doi: 10.1021/acsabm.0c01227. Epub 2021 Jan 11.
9
Non-Polymeric Nanogels as Versatile Nanocarriers: Intracellular Transport of the Photosensitizers Rose Bengal and Hypericin for Photodynamic Therapy.非聚合纳米胶束作为多功能纳米载体:用于光动力疗法的光敏剂孟加拉玫瑰红和金丝桃素的细胞内运输。
ACS Appl Bio Mater. 2021 Apr 19;4(4):3658-3669. doi: 10.1021/acsabm.1c00139. Epub 2021 Apr 1.
10
Preliminary Study of New Gallium-68 Radiolabeled Peptide Targeting NRP-1 to Detect Brain Metastases by Positron Emission Tomography.新型镓-68 放射性标记神经纤毛蛋白-1 肽用于正电子发射断层扫描探测脑转移的初步研究。
Molecules. 2021 Nov 30;26(23):7273. doi: 10.3390/molecules26237273.